Skip to main content
XRNChiron Real Estate Inc.Sell5.4·$36.59-2.58%
SellModerate Confidence
Investment thesis

Chiron Real Estate pairs notable insider buying ($625K, 0.114% of market cap) and elite FCF-backed quality (Rule of 40 of 74) with a bullish golden-cross breakout and a cheap 7.4x P/OCF multiple, though the stock already trades past its analyst target.

Thesis pillars

  • Notable Insider Buying Bullish SignalStable
  • Elite Rule Of 40 Fcf PositiveStable
  • Golden Cross Breakout SetupStable
  • +2 more pillars — see the Why tab for full reasoning

Full reasoning →

Open full analysis

Chiron Real Estate Inc. (XRN) Stock Analysis

Breakout setup

SellValueModerate Confidence

Real Estate · REIT - Healthcare Facilities

Sell if holding. Analyst target reached at $36.59 — A.R:R is negative (-1.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Property Type: Medical Office Building (MOB) (71.9%).

Chiron Real Estate (formerly Global Medical REIT) is an internally managed REIT that owns 189 healthcare facilities totaling 5.1 million square feet, leased primarily to physician groups and regional or national healthcare systems under triple-net leases. Medical office... Read more

$36.59+3.5% A.UpsideScore 5.4/10#8 of 16 REIT - Healthcare Facilities
QualityF-score6 / 9FCF yield16.50%
IncomeYield15.35%(5y avg 10.00%)Payout1114.29%
Stop $34.63Target $37.88(resistance)A.R:R -1.8:1
Analyst target$37.88+3.5%8 analysts
$37.88our TP
$36.59price
$37.88mean
$9
$46

Sell if holding. Analyst target reached at $36.59 — A.R:R is negative (-1.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Property Type: Medical Office Building (MOB) (71.9%). Chart setup: Golden cross, above all MAs, RSI 56, MACD bullish. Score 5.4/10, moderate confidence.

Passes 5/8 gates (clean insider activity, news events none recent, earnings proximity 27d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.

10-K grounded · weekly refresh

About Chiron Real Estate Inc.

About Chiron Real Estate Inc.

Chiron Real Estate's 189-building healthcare portfolio, spanning approximately 5.1 million square feet of leasable space, generates $118.8 million in annualized base rent, with medical office buildings accounting for 71.9% of that rent. Texas is the company's single largest state exposure at 17.0% of annualized base rent, part of a broader concentration the REIT discloses across Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois.

Most of Chiron's healthcare facilities are leased to a single tenant under triple-net leases, meaning tenants bear property-level operating costs and the REIT collects contracted base rent; a smaller share of multi-tenant properties operate under gross or modified gross lease structures. Tenants named LifePoint Health, Encompass Health Corporation, and Memorial Health System each account for at least 5% of annualized base rent, together representing 18.1% of the total. The company's lease maturity ladder is staggered, with only 7.4% of annualized base rent expiring in 2026 and the largest single-year rollovers concentrated in 2029 (15.8%) and 2027 (13.7%). Chiron also holds a 12.5% stake in a joint venture with Heitman, a real estate investment firm with more than $48 billion in assets under management, through which it earns fees for sourcing and managing two healthcare assets, and 12 of its buildings sit on ground leases covering 13.2% of total leasable square feet.

Show full overview

Chiron's own risk factors flag a structural vulnerability distinct from simple revenue-share math: because most of its healthcare facilities are occupied by a single tenant, the REIT says it may have difficulty finding suitable replacement tenants if a tenant defaults or fails to renew, especially for facilities in smaller markets where alternative healthcare operators may be scarce. That single-tenant-per-property design means the loss of even one mid-sized lease can leave an entire building vacant rather than partially vacant, a different risk profile than a multi-tenant office or retail REIT would face from the same dollar amount of lease expiration.

See also: Real Estate · REIT - Healthcare Facilities

From Chiron Real Estate Inc.'s most recent 10-K filing, extracted July 6, 2026.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Tue, Aug 4, 202627d to earnings· next earnings call

Thesis

Rewards
Positive insider activity
Risks
Concentration risk — Property Type: Medical Office Building (MOB) (71.9%)
Analyst target reached - limited upside remaining
Leverage penalty (D/E 1.3): -0.5

Key Metrics

P/E (TTM)
P/E (Fwd)-24.5
Mkt Cap$590M
EV/EBITDA14.3
Profit Mgn-5.1%
ROE-1.7%
Rev Growth10.1%
Beta1.12
Dividend15.35%
Rating analysts13

Quality Signals

Piotroski F6/9MoatNarrow

Options Flow

P/C0.43bullish
IV81%elevated

Concentration Risks(10-K Item 1A)

  • HIGHPropertyMedical Office Building (MOB)72%
    10-K Item 1: 'Medical Office Building (MOB) (2)| ​| 4,035,663| ​| 79.1| % | $| 85,397| ​| 71.9| %'
  • MEDIUMGeographicTexas, Florida, Ohio, Arizona, Pennsylvania, and Illinois
    10-K Item 1: 'We have significant geographic concentration in a small number of states, including Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois. Economic and other conditions that negatively affect those states and our tenants in those states could have a greater effect on our revenues than if our properties were more geographically diverse'
  • MEDIUMTenantsignificant tenants (≥5% of ABR)
    10-K Item 1: 'The following tenants each account for at least 5% of our annualized base rent as of December 31, 2025.'

Material Events(8-K, last 90d)

  • 2026-05-20Item 5.02LOW
    Board expanded from six to seven members and appointed Charles Fitzgerald, Founder of Maewyn Capital Partners, as a director effective May 20, 2026, serving on the Compensation and Nominating and Corporate Governance Committees. Routine board addition, no departure.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Dividend Safety
4.8
Erm
5.0
Earnings Timing
5.0
Earnings concerns: 0B/4MYield trap warning: high yield but unsafe
GatesMomentum 4.2<4.5A.R:R -1.8=NEGATIVEExecutive change: officer departure/appointmentInsider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 27d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Aggressive
RSI
56 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $34.57Resistance $38.65

Price Targets

$35
$38
A.Upside+3.5%
A.R:R-1.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-9.9% upside)
! momentum at 4.2 (below the engine's 4.5 threshold)
! Negative risk/reward — downside exceeds upside

Earnings

M
M
M
M
0/4 beats
Next Earnings2026-08-04 (27d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is XRN stock a buy right now?

Sell if holding. Analyst target reached at $36.59 — A.R:R is negative (-1.8) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Property Type: Medical Office Building (MOB) (71.9%). Chart setup: Golden cross, above all MAs, RSI 56, MACD bullish. Prior stop was $34.63. Score 5.4/10, moderate confidence.

What is the XRN stock price target?

Take-profit target: $37.88 (+3.5% upside). Prior stop was $34.63. Stop-loss: $34.63.

What are the risks of investing in XRN?

Concentration risk — Property Type: Medical Office Building (MOB) (71.9%); Analyst target reached - limited upside remaining; Leverage penalty (D/E 1.3): -0.5.

Is XRN overvalued or undervalued?

Chiron Real Estate Inc. trades at a P/E of N/A (forward -24.5). TrendMatrix value score: 5.1/10. Verdict: Sell.

What do analysts say about XRN?

13 analysts cover XRN with a consensus score of 3.7/5. Average price target: $38.

What does Chiron Real Estate Inc. do?Chiron Real Estate (formerly Global Medical REIT) is an internally managed REIT that owns 189 healthcare facilities...

Chiron Real Estate (formerly Global Medical REIT) is an internally managed REIT that owns 189 healthcare facilities totaling 5.1 million square feet, leased primarily to physician groups and regional or national healthcare systems under triple-net leases. Medical office buildings make up 71.9% of the portfolio's $118.8 million in annualized base rent, and the company reported significant geographic concentration in Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois as of December 31, 2025.

Related stocks: SBRA (Sabra Health Care REIT, Inc.) · MPT (Medical Properties Trust, Inc.) · CHCT (Community Healthcare Trust Inco) · UHT (Universal Health Realty Income ) · NHI (National Health Investors, Inc.)
Home Stocks XRN

Latest news

No recent news